https://www.selleckchem.com/EGFR(HER).html
7 ± 19.3 μmol/L and 157.4 ± 16.4 μmol/L, respectively, 48 h after intervention (P 0.05). The median length of hospitalisation in the treatment group was approximately 1 day lower than the control group (logrank test P value 0.001). The study showed that the addition of UDCA to phototherapy accelerates the reduction of total bilirubin level in neonates with G6PD deficiency and can reduce the duration of hospitalisation. The study showed that the addition of UDCA to phototherapy accelerates the reduction of total bilirubin level in neon
Mi piace
Commento
Condividi
